Siegfried Holding AG (SGFEF)

Market Cap	4.03B -9.1%
Revenue (ttm)	1.67B +2.6%
Net Income	212.70M +5.4%
EPS	4.84 +4.1%
Shares Out	n/a
PE Ratio	18.93
Forward PE	18.16
Dividend	n/a
Ex-Dividend Date	n/a

Volume	15
Average Volume	234
Open	100.00
Previous Close	104.61
Day's Range	100.00 - 100.00
52-Week Range	100.00 - 1,025.00
Beta	0.74
RSI	35.92
Earnings Date	Aug 21, 2026

About Siegfried Holding AG

Siegfried Holding AG, together with its subsidiaries, engages in contract development and manufacturing of active pharmaceutical ingredient (API) and finished dosage forms worldwide. It offers drug substances, including exclusive synthesis that manufactures custom APIs. The company also offers an API portfolio, including non-exclusive APIs and pharma-grade substances that focus on anesthetics, pain and addiction treatment applications, and central nervous and respiratory diseases, as well as caffeine for human health and nutrition. In addition,...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1873
• Employees: 3,891
• Stock Exchange: OTCMKTS
• Ticker Symbol: SGFEF

Financial Performance

In 2025, Siegfried Holding AG's revenue was 1.33 billion, an increase of 2.57% compared to the previous year's 1.29 billion. Earnings were 168.66 million, an increase of 5.37%.

Financial numbers in CHF